肝脏影像报告和数据系统对采用MRI诊断肝细胞癌研究的影响
该系统综述纳入2011至2019年间179项评估肝脏MRI诊断肝细胞癌效能的原著,按发表年份分三组比较。采用LI-RADS词典和诊断标准的比例在2011-2013、2014-2016、2017-2019年分别为0.0%、18.4%、56.6%和0.0%、22.9%、60.7%(P均<0.001)。使用与未使用LI-RADS 2018版的研究间敏感度和特异度无显著差异。
要点
- 2017-2019年56.6%的肝脏MRI诊断肝细胞癌研究采用LI-RADS词典,60.7%采用其诊断标准。
- 使用LI-RADS 2018版与未使用LI-RADS的研究间敏感度86.3% vs. 77.7%(P=0.102)、特异度91.4% vs. 89.9%(P=0.770)无显著差异。
- LI-RADS推荐MRI技术的采用率三组间无显著差异(P=0.951)。
核心结论
- LI-RADS使肝脏MRI诊断肝细胞癌研究中所用的图像分析方法和诊断标准发生了显著变化。
研究设计与样本
- 系统综述,检索MEDLINE、EMBASE和Cochrane数据库2011至2019年报告肝脏MRI诊断肝细胞癌效能的原著,共纳入179项研究。
- 按发表年份分为2011-2013年、2014-2016年和2017-2019年三组,比较采用LI-RADS推荐MRI技术、LI-RADS词典图像分析方法和LI-RADS诊断标准的研究百分比。
- 比较使用LI-RADS与未使用LI-RADS研究间的合并敏感度和特异度。
诊断标准与关键数值
- 采用LI-RADS推荐MRI技术的研究百分比:2011-2013年77.8%,2014-2016年85.7%,2017-2019年84.2%,无显著差异(P=0.951)。
- 遵循LI-RADS词典的研究百分比:2011-2013年0.0%,2014-2016年18.4%,2017-2019年56.6%(P<0.001)。
- 使用LI-RADS诊断影像标准的研究百分比:2011-2013年0.0%,2014-2016年22.9%,2017-2019年60.7%(P<0.001)。
- 未使用LI-RADS与使用LI-RADS 2018版的研究:敏感度86.3% vs. 77.7%(P=0.102),特异度91.4% vs. 89.9%(P=0.770),均无显著差异。
- 异质性:敏感度I²=94.3% vs. 86.7%,特异度I²=86.6% vs. 53.2%(未使用LI-RADS vs. 使用LI-RADS 2018版)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Since its introduction in 2011, the CT/MRI diagnostic Liver Imaging Reporting and Data System (LI-RADS) has been updated in 2014, 2017, and 2018. We evaluated the impact of CT/MRI diagnostic LI-RADS on liver MRI research methodology for the diagnosis of hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: The MEDLINE, EMBASE, and Cochrane databases were searched for original articles reporting the diagnostic performance of liver MRI for HCC between 2011 and 2019. The MRI techniques, image analysis methods, and diagnostic criteria for HCC used in each study were investigated. The studies were classified into three groups according to the year of publication (2011-2013, 2014-2016, and 2017-2019). We compared the percentage of studies adopting MRI techniques recommended by LI-RADS, image analysis methods in accordance with the lexicon defined in LI-RADS, and diagnostic criteria endorsed by LI-RADS. We compared the pooled sensitivity and specificity between studies that used the LI-RADS and those that did not.
RESULTS: This systematic review included 179 studies. The percentages of studies using imaging techniques recommended by LI-RADS were 77.8% for 2011-2013, 85.7% for 2014-2016, and 84.2% for 2017-2019, with no significant difference (p = 0.951). After the introduction of LI-RADS, the percentages of studies following the LI-RADS lexicon were 0.0%, 18.4%, and 56.6% in the respective periods (p < 0.001), while the percentages of studies using the LI-RADS diagnostic imaging criteria were 0.0%, 22.9%, and 60.7%, respectively (p < 0.001). Studies that did not use the LI-RADS and those that used the LI-RADS version 2018 showed no significant difference in sensitivity and specificity (86.3% vs. 77.7%, p = 0.102 and 91.4% vs. 89.9%, p = 0.770, respectively), with some difference in heterogeneity (I² = 94.3% vs. 86.7% in sensitivity and I² = 86.6% vs. 53.2% in specificity).
CONCLUSION: LI-RADS imparted significant changes in the image analysis methods and diagnostic criteria used in liver MRI research for the diagnosis of HCC.
引用
- Ahn Y, Choi SH, Jang JK, et al. Impact of the Liver Imaging Reporting and Data System on Research Studies of Diagnosing Hepatocellular Carcinoma Using MRI. Korean J Radiol. 2022. PMID: 35289147. doi:10.3348/kjr.2021.0393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。